Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials

by palligoelme@gmail.com | Mar 17, 2025 | Clinical Trials

​    

Post-polio immune therapy aces human trials

by palligoelme@gmail.com | Mar 16, 2025 | Clinical Trials

​  Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors years after the initial infection and be very debilitating, have produced positive results.  Recent human trials of a new one-year-long...

Novel cancer therapy works for 73 per cent Indian patients in clinical trials: Why the Lancet report is significant

by palligoelme@gmail.com | Mar 16, 2025 | Clinical Trials

​  This is the first clinical trial of CAR T-cell therapy from India to be published in journal  This is the first clinical trial of CAR T-cell therapy from India to be published in journal 

Findings on Roflumilast Cream 0.05% for Children with Atopic Dermatitis, with Mercedes Gonzalez, MD

by palligoelme@gmail.com | Mar 15, 2025 | Clinical Trials

​  This interview highlights recent findings on roflumilast cream 0.05% for patients aged 2 to 5 years with mild to moderate atopic dermatitis.  This interview highlights recent findings on roflumilast cream 0.05% for patients aged 2 to 5 years with mild to moderate...

Nivolumab Yields High Clinical CR Rates Allowing for Surgery Omission in dMMR/MSI-H Endometrial Cancer

by palligoelme@gmail.com | Mar 15, 2025 | Clinical Trials

​  Nivolumab elicited PR/CRs in all patients treated with resectable dMMR endometrial cancer and no patients experienced disease recurrence during follow-up.  Nivolumab elicited PR/CRs in all patients treated with resectable dMMR endometrial cancer and no patients...